Walleye Trading LLC Intellia Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $942,942 - $1.28 Million	47,100 Added 1385.29%	50,500 $1.13 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $207,234 - $285,360	-8,700 Reduced 71.9%	3,400 $93,000
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $27,792 - $38,808	-1,200 Reduced 9.02%	12,100 $368,000
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $613,428 - $888,132	-19,400 Reduced 59.33%	13,300 $420,000
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $1.04 Million - $1.38 Million	30,000 Added 1111.11%	32,700 $1.33 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $143,190 - $192,726	-4,300 Reduced 61.43%	2,700 $100,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $292,248 - $551,672	-8,800 Reduced 55.7%	7,000 $244,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $53,920 - $71,700	1,000 Added 6.76%	15,800 $884,000
Q2 2022 Aug 08, 2022	BUY	$38.49 - $76.21 $11,547 - $22,862	300 Added 2.07%	14,800 $766,000
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $5,827 - $11,899	100 Added 0.69%	14,500 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $322,432 - $442,752	-3,200 Reduced 18.18%	14,400 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $860,405 - $1.15 Million	6,500 Added 58.56%	17,600 $2.36 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $66,968 - $178,101	1,100 Added 11.0%	11,100 $1.8 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $465,900 - $836,800	10,000 New	10,000 $803,000
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $185,968 - $306,926	-19,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $205,471 - $348,099	19,700 New	19,700 $289,000
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $366,432 - $486,024	-26,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $193,129 - $266,062	15,100 Added 133.63%	26,400 $451,000
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $75,174 - $179,058	6,600 Added 140.43%	11,300 $154,000
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $1.05 Million - $1.33 Million	-40,700 Reduced 89.65%	4,700 $135,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $626,626 - $963,727	31,300 Added 221.99%	45,400 $1.24 Million
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $178,756 - $321,540	9,200 Added 187.76%	14,100 $297,000
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $85,211 - $152,488	4,900	4,900 $94,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$125 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$98.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$97.9 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$52.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$50.5 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account